Artificial Intelligence
Pathomation and Mindpeak: Mindpeak’s CE-IVD certified algorithms are now fully integrated and operational within Pathomation’s trusted digital pathology platform, built for interoperability and control, enabling frictionless AI adoption in...
Dr. Lal PathLabs: It accurately detected single-cell and micrometastases that had been missed during manual reviews. Results were later validated through IHC, confirming the system’s reliability Dr. Lal PathLabs (DLPL) has adopted a deep...
The latest from the Proscia blog Emerging biotechs, along with their small and mid-sized CRO counterparts, are establishing themselves as key players advancing the next generation of therapies. So, in line with our mission to rewire...
OREM, Utah--(BUSINESS WIRE)--Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced that its platform, Techcyte Fusion™ (research use only (RUO) in the US, CE-IVDD-marked in...
Artera: Novel risk stratification tool advances the frontier of precision oncology by providing access to insights informing critical on-the-ground treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of...
SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the...
